Episode Details

The discussion begins with Nora, who provides insights into the importance and execution of capacity assessments within the clinical framework. She clarifies that while neuropsychologists are typically associated with these assessments, other clinicians, including general practitioners (GPs), can conduct them if the case is straightforward. If a patient presents with early-stage dementia and seems to understand the implications of a specific decision, a GP can evaluate their capacity. However, for more complex cases where cognitive impairment or insight levels are unclear, referring the patient for a neuropsychological evaluation is advisable. The role of neurologists in making capacity assessments is also highlighted, noting that many referrals come from this specialty.

Continuing the conversation, the panel addresses practical aspects of neuropsychological assessments, such as their accessibility, duration of validity, and costs. It is emphasized that capacity is presumed until evidence suggests otherwise; hence re-assessment is not a regular requirement but rather situational. Nora mentions that private neuropsychological assessments can be expensive, costing around $2,000, which can vary based on the specifics of the evaluation. Accessibility in public health settings is also a topic of concern, as Nora elaborates on Medicare provisions allowing patients to receive neuropsychological services at no cost, albeit with limitations regarding medico-legal assessments and long waiting lists for public services.

The discussion shifts focus as Candice introduces the topic of migraine, particularly in patients with past migraine histories who develop new headache symptoms. She emphasizes the importance of reassessment when patients report different types of headaches, as this could indicate new underlying neurological conditions. In these situations, brain imaging may be warranted, typically starting with an MRI, although routine follow-ups may not be necessary unless new clinical indicators arise. The link between cognitive processing and headache is noted, especially in patients whose MRI results reveal white matter changes, leading to concerns about cognitive decline.

Nora enriches the discussion by exploring the neuropsychological testing process further, particularly regarding conditions like adult-onset ADHD, anxiety, and depression, providing insights into the distinct cognitive profiles associated with these disorders. This information proves crucial for clinicians assessing capacity and cognitive functionality in patients with such conditions, allowing for a nuanced interpretation of their capacity status.

Candice then transitions the conversation towards treatment options for chronic migraines, touching on criteria for accessing expensive therapies through PBS, the complexities surrounding prescriptions, and the importance of fitting patient needs within treatment guidelines. She discusses challenges in prescribing medications for individuals who may not fully meet the PBS criteria, as well as considerations for women in specific life stages when managing migraines.

The complexities of managing migraines in the context of pregnancy and perimenstrual headaches are discussed. Suggestions include the use of estrogen patches or anti-inflammatory medications timed with menstrual cycles to prevent migraine onset. Candice emphasizes the limited options available during pregnancy, thus presenting the need for careful management of migraine prophylaxis in this demographic.

In closing, the conversation returns to contraceptive considerations for women experiencing migraines, particularly those with auras. The panel outlines the risks of stroke associated with hormonal contraceptives in these patients and the need for thorough patient education and informed consent regarding treatment options. Alternatives such as low-dose oral contraceptives are discussed, emphasizing the importance of shared